Probiotics for preventing bone loss during breast cancer hormone therapy
Part of Cancer, Skin clinical trials.
This trial tests if a probiotic supplement can help prevent bone loss in women with HR-positive breast cancer who are starting an aromatase inhibitor. You would take the probiotic daily and provide blood and stool samples to see how it affects your bone health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have stage 0 to III hormone receptor-positive breast cancer.
- You are about to start an aromatase inhibitor (like letrozole, anastrozole, or exemestane), with or without ovarian suppression therapy.
- You have not had certain bone medications or treatments recently (like bisphosphonates or denosumab).
- You are not taking a CDK 4/6 inhibitor (like abemaciclib, ribociclib, or palbociclib).
- You are willing to provide stool and blood samples and attend study visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether skipping chemotherapy and using only hormone therapy with a drug called ribociclib works as well as chemotherapy followed by hormone therapy with ribociclib for certain early breast cancers that have a low risk of coming back.
This study tests whether taking a probiotic supplement affects the bacteria and fungi in your gut, which may be linked to your breast cancer. You'll take a daily probiotic and have your diet and activity stay the same, to see if it helps your body respond to treatment.
This trial tests whether taking a probiotic supplement can help breast cancer patients going through chemotherapy. If you are between 20 and 80 years old, have stage I-III breast cancer, and are receiving certain chemo drugs, this study may be for you.
This trial tests whether a special probiotic supplement (good bacteria) can reduce belly discomfort caused by abemaciclib, a hormone therapy drug for early breast cancer. You would take the supplement alongside your cancer treatment to see if it helps with stomach side effects.
This trial tests a combination of vitamin K, D-chiro inositol, and α-lactalbumin to help maintain bone strength in women with breast cancer who are on hormone therapy and have low vitamin D. It aims to see if these supplements improve bone health while you take a standard bone medication (alendronate).
This study tests whether a daily probiotic supplement can help prevent bone loss in adults aged 60 and older. It is designed for people who have chosen not to take standard osteoporosis medications.
Hear when a new Anatomic Stage 0 Breast Cancer AJCC v8 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.